NCT02034110 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 13
- group Id
- BG004
- value
- 45
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 55
- group Id
- BG007
- value
- 10
- group Id
- BG008
- value
- 206
- units
- Participants
- groups
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG000
- title
- Anaplastic Thyroid Cancer (ATC)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG001
- title
- Biliary Tract Cancer (BTC)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG002
- title
- Gastrointestinal Stromal Tumor (GIST)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG003
- title
- Low Grade (WHO G1/G2) Glioma (LGG)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG004
- title
- High Grade (WHO G3/G4) Glioma (HGG)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG005
- title
- Adenocarcinoma of the Small Intestine (ASI)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG006
- title
- Hairy Cell Leukemia (HCL)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG007
- title
- Multiple Myeloma (MM)
- description
- Total of all reporting groups
- id
- BG008
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.53
- value
- 69.6
- group Id
- BG001
- spread
- 11.88
- value
- 57.0
- comment
- Only one participant analyzed
- group Id
- BG002
- spread
- NA
- value
- 77.0
- group Id
- BG003
- spread
- 11.51
- value
- 33.1
- group Id
- BG004
- spread
- 14.70
- value
- 41.9
- group Id
- BG005
- spread
- 3.21
- value
- 58.3
- group Id
- BG006
- spread
- 10.77
- value
- 64.8
- group Id
- BG007
- spread
- 6.89
- value
- 66.9
- group Id
- BG008
- spread
- 16.40
- value
- 57.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 22
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 90
- title
- Female
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 23
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 47
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 116
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 4
- title
- African American/African Heritage
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- title
- Asian - Central/South Asian Heritage
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 17
- title
- Asian - East Asian Heritage
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 7
- title
- Asian - Japanese Heritage
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 4
- title
- Asian - South East Asian Heritage
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 5
- title
- White - Arabic/North African Heritage
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 32
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 48
- group Id
- BG007
- value
- 8
- group Id
- BG008
- value
- 157
- title
- White - White/Caucasian/European heritage
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 10
- title
- Missing
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 14
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 25
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 72
- title
- Grade 0
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 24
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 27
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 118
- title
- Grade 1
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 16
- title
- Grade 2
- description
- The Eastern Cooperative Oncology Group Performance Status (ECOG PS) score classifies participants according to their functional impairment, with scores ranging from 0 (fully active) to 5 (dead). ECOG PS: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2 = ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 13
- group Id
- BG004
- value
- 45
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 55
- group Id
- BG007
- value
- 10
- group Id
- BG008
- value
- 206
- units
- Participants
- groups
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG000
- title
- Anaplastic Thyroid Cancer (ATC)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG001
- title
- Biliary Tract Cancer (BTC)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG002
- title
- Gastrointestinal Stromal Tumor (GIST)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG003
- title
- Low Grade (WHO G1/G2) Glioma (LGG)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG004
- title
- High Grade (WHO G3/G4) Glioma (HGG)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG005
- title
- Adenocarcinoma of the Small Intestine (ASI)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG006
- title
- Hairy Cell Leukemia (HCL)
- description
- All subjects enrolled received oral dabrafenib 150 mg bid in combination with oral trametinib 2 mg once daily. Subjects continued treatment until an unacceptable toxicity, disease progression, or death.
- id
- BG007
- title
- Multiple Myeloma (MM)
- description
- Total of all reporting groups
- id
- BG008
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.53
- value
- 69.6
- group Id
- BG001
- spread
- 11.88
- value
- 57.0
- comment
- Only one participant analyzed
- group Id
- BG002
- spread
- NA
- value
- 77.0
- group Id
- BG003
- spread
- 11.51
- value
- 33.1
- group Id
- BG004
- spread
- 14.70
- value
- 41.9
- group Id
- BG005
- spread
- 3.21
- value
- 58.3
- group Id
- BG006
- spread
- 10.77
- value
- 64.8
- group Id
- BG007
- spread
- 6.89
- value
- 66.9
- group Id
- BG008
- spread
- 16.40
- value
- 57.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 22
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 90
- title
- Female
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 23
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 47
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 116
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 4
- title
- African American/African Heritage
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- title
- Asian - Central/South Asian Heritage
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 17
- title
- Asian - East Asian Heritage
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 7
- title
- Asian - Japanese Heritage
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 4
- title
- Asian - South East Asian Heritage
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 5
- title
- White - Arabic/North African Heritage
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 32
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 48
- group Id
- BG007
- value
- 8
- group Id
- BG008
- value
- 157
- title
- White - White/Caucasian/European heritage
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 10
- title
- Missing
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 14
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 25
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 72
- title
- Grade 0
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 24
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 27
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 118
- title
- Grade 1
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 16
- title
- Grade 2
- description
- The Eastern Cooperative Oncology Group Performance Status (ECOG PS) score classifies participants according to their functional impairment, with scores ranging from 0 (fully active) to 5 (dead). ECOG PS: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2 = ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle